Top Markets
Coin of the day
AIM ImmunoTech Inc. AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

AIM
Rang in Aktien #38741
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida,... AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.
Aktienkurs
$0.2438
Marktkapitalisierung
$829.78K
Veränderung (1 Tag)
-5.61%
Veränderung (1 Jahr)
-89.93%
Land
US
Handel AIM ImmunoTech Inc. (AIM)

Kategorie

Preis AIM mit Marktkapitalisierung von B
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
AIM
$0.2438
Marktkapitalisierung von AIM ImmunoTech Inc.(AIM)
Marktkapitalisierung: $829.78K
Mit Stand August 2026 hat AIM ImmunoTech Inc. eine Marktkapitalisierung von $829.78K. Das macht AIM ImmunoTech Inc. laut unseren Daten zum 38741st wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von AIM ImmunoTech Inc. von 1996 bis 2026
AIM im Vergleich zu den Top 5 der beliebtesten stocks
Preis für AIM Vermögenswert B Marktkapitalisierung von B Ergebnisse
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,602,233 $829.78K
$5.453T +657,191,301.43%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,317,237 $829.78K
$4.483T +540,294,104.12%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,222,687 $829.78K
$4.161T +501,512,053.44%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,083,210 $829.78K
$3.687T +444,302,723.68%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$832,840 $829.78K
$2.835T +341,607,775.34%